Pono (Drug Discovery) Overview
- Year Founded
-
2012

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Pono (Drug Discovery) General Information
Description
Developer of pharmaceuticals to treat cancer and bacterial infections. The company is developing a new antibiotic technology that integrates traditional beta-lactams and ionic silver. The company also is developing a proteasome inhibitor targeting multiple myeloma and other difficult-to-treat cancers.
Contact Information
Website
www.ponocorp.comCorporate Office
- 2615 South King Street
- Suite 310
- Honolulu, HI 96826
- United States
Corporate Office
- 2615 South King Street
- Suite 310
- Honolulu, HI 96826
- United States
Pono (Drug Discovery) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Apr-2018 | Completed | Out of Business | |||
1. Early Stage VC | 13-Mar-2012 | Completed | Startup |
Pono (Drug Discovery) Comparisons
Industry
Financing
Details
Pono (Drug Discovery) Competitors (1)
One of Pono (Drug Discovery)’s competitors is Kala Bio, a Formerly VC-backed company based in Arlington, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Kala Bio | Formerly VC-backed | Arlington, MA |
Pono (Drug Discovery) Patents
Pono (Drug Discovery) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20150150995-A1 | Conjugated anti-microbial compounds and conjugated anti-cancer compounds and uses thereof | Inactive | 09-Aug-2012 | ||
US-20150336915-A1 | Structures of proteasome inhibitors and methods for synthesizing and use thereof | Inactive | 02-Jul-2012 | ||
US-20140187526-A1 | Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition | Inactive | 14-Nov-2007 | ||
US-20100267070-A1 | Pharmaceutical compositions for the treament of conditions responsive to proteasome inhibition | Active | 14-Nov-2007 | ||
US-8597904-B2 | Pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition | Inactive | 14-Nov-2007 | C07D245/02 |
Pono (Drug Discovery) FAQs
-
When was Pono (Drug Discovery) founded?
Pono (Drug Discovery) was founded in 2012.
-
Where is Pono (Drug Discovery) headquartered?
Pono (Drug Discovery) is headquartered in Honolulu, HI.
-
What industry is Pono (Drug Discovery) in?
Pono (Drug Discovery)’s primary industry is Drug Discovery.
-
Is Pono (Drug Discovery) a private or public company?
Pono (Drug Discovery) is a Private company.
-
What is Pono (Drug Discovery)’s current revenue?
The current revenue for Pono (Drug Discovery) is
. -
How much funding has Pono (Drug Discovery) raised over time?
Pono (Drug Discovery) has raised $1.5M.
-
Who are Pono (Drug Discovery)’s competitors?
Kala Bio is a competitor of Pono (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »